MEDIVIR PROPOSES DIRECTED ISSUE OF APPROXIMATELY SEK 28 MILLION TO THE COMPANY’S EXISTING SPECIALIST INVESTOR LINC
The Board of Directors in Medivir AB (publ) (”Medivir” or the ”Company”) has decided to summon an extraordinary general meeting on 11 March 2021 to propose a directed issue (the ”Directed Issue”) to the Company’s existing specialist investor LINC AB (”LINC”), controlled by the Company’s board member Bengt Julander.In the rights issue, from which the preliminary results was announced on 5 February 2021 (the ”Rights Issue”), Bengt Julander (through LINC) among others entered into subscription and guarantee commitments. The Rights Issue was substantially oversubscribed and no guarantee